Back to search

Article

Early Use of Low Dose Rituximab in Anti Acetylcholine Receptor Generalised Myasthenia Gravis in South Wales – a Retrospective Study

2026-06-08

Abstract excerpt

<title>Abstract</title> <p>Background Early B-cell depletion with rituximab may improve outcomes in acetylcholine receptor (AChR)–positive generalized myasthenia gravis (MG), but data on early low-dose use are limited. Objective To assess the effectiveness, steroid-sparing effect, and safety of early low-dose rituximab in non-thymomatous, immunosuppression-naïve generalized AChR-positive MG. Methods Retrospect...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c3ed46f3-0e8c-581d-a784-67ae366f8d89
DOI
10.21203/rs.3.rs-9552683/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Early Use of Low Dose Rituximab in Anti Acetylcholine Receptor Generalised Myasthenia Gravis in South Wales – a Retrospective StudyDOI 10.21203/rs.3.rs-9552683/v1
Select a neighboring publication to make it the new centre.